Current investigations into retatrutide, a dual agonist for GLP-1 and GIP receptors, are demonstrating significant outcomes in treating weight gain and related 2 diabetes. Preclinical data suggest a unique process https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/